Promising new cancer therapy appears to be extremely potent against tuberculosis

A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB).

Congress Making Progress on Bills to Regulate PBMs

Confused by all the bills being introduced in Congress to regulate pharmacy benefit managers (PBMs)? You’re not alone. Not only is the Senate Finance Committee

August 4, 2023

Merck’s KEYTRUDA regimen gets positive EMA CHMP opinion

Share this article Merck’s Keytruda received approval in the US in October 2023. Credit: Atmosphere1 / Shutterstock.com. Merck (MSD)’s anti-programmed death receptor-1 (PD-1) therapy Keytruda

February 26, 2024

Study proposes new model for treating stress-related exhaustion

A new thesis at Uppsala University questions the traditional view of stress-induced exhaustion disorder. A new model is proposed in its place that puts more

June 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.